Preview Mode Links will not work in preview mode

Jul 27, 2020

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Interview with Dr Birrer on the following topics:

  • Diagnosis and management of endometrial cancer with POLE mutation (00:00)
  • Mechanism of action and tolerability of pembrolizumab/lenvatinib in patients with endometrial cancer (3:39)
  • Clinical outcomes with and optimal integration of ICIs for ovarian cancer and cervical cancer (14:53)

CME information and select publications